MedTrace Logo

TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

NCT01066520 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 449

Last updated 2014-01-09

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine the efficacy of Traumeel S (both ointment and gel) compared to another antiinflammatory drug called Diclofenac in patients with a sprained ankle.

Conditions

  • Sprain of Ankle

Interventions

DRUG

Traumeel S ointment

2 g, 3 times daily topical during 14 days

DRUG

Traumeel S gel

2 g, 3 times daily topical during 14 days

DRUG

Diclofenac gel

2 g, 3 times daily topical during 14 days

Sponsors & Collaborators

  • Biologische Heilmittel Heel GmbH

    lead INDUSTRY

Principal Investigators

  • Carlos Gonzalez de Vega, MD · National Coordinating Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-09-30
Completion
2012-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01066520 on ClinicalTrials.gov